Skip to main content

Understanding Cannabis ETFs’ Wacky Divergence

One of the top-performing thematic segments this year is cannabis. A major catalyst has been the proposed descheduling of it from a Schedule I to a Schedule III drug under the Controlled Substances Act (CSA). That means it would be reclassified into a lower category below hard drugs like heroin and cocaine. Back in August, [...] The post Understanding Cannabis ETFs’ Wacky Divergence appeared first on ETF Trends .
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.